Which wash heals hips best? new trial tests Povidone-Iodine vs chlorhexidine
NCT ID NCT07104084
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two antiseptic washes used during hip replacement surgery to see which one helps wounds heal better. About 420 adults with hip osteoarthritis or avascular necrosis will be randomly assigned to receive either povidone-iodine or chlorhexidine wash after their new hip joint is placed. Researchers will evaluate scar appearance and complications like drainage or infection at 2 and 6 weeks after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- povidone-iodine or chlorhexidine antiseptic wash
- What this could lead to
- If one wash proves better, surgeons may adopt it to reduce wound problems after hip replacement.
- What could go wrong
- This is a small, early-stage comparison of two standard washes, so differences may be minor or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 420 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * osteoarthritis or avascular necrosis of the femoral head, failed conservative management, indicated for total hip replacement Exclusion Criteria: * reported or documented allergy to chlorhexidine or povidone-iodine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Avascular necrosis of femoral head are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UPMC East
RECRUITINGMonroeville, Pennsylvania, 15146, United States
-
UPMC Shadyside
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain waves may reveal how well a sedative blocks surgical pain
- Hip replacement showdown: does the labrum stay or go?
- Can physical therapy beamed into rural homes ease arthritis pain?
- Can catching anemia months before joint surgery speed recovery?
- Can a new turkish questionnaire accurately measure hip osteoarthritis?
- Could a 2-Hour online class before hip surgery boost recovery?